Old age and male sex are associated with increased risk of asymptomatic erosive esophagitis: Analysis of data from local health examinations by the Korean National Health Insurance Corporation

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 6, 2011, Pages 1034-1038

  Cho, Jae Hee ^a,b   Kim, Hee Man ^a,b   Ko, Geun Jun ^a   Woo, Myoung Lyeol ^a   Moon, Chang Mo ^a,b   Kim, Yu Jin ^a,b   Han, Ki Jun ^a   Song, Si Young ^b   Cho, Hyeon Geun ^a  

^a Kwandong University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

Author keywords

Asymptomatic; Erosive; Reflux esophagitis

Indexed keywords

ADULT; ARTICLE; ASYMPTOMATIC DISEASE; DUODENUM ULCER; ESOPHAGOGASTRODUODENOSCOPY; FEMALE; GROUPS BY AGE; HIATUS HERNIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; NATIONAL HEALTH INSURANCE; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; REFLUX ESOPHAGITIS; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOUTH KOREA;

EID: 79955906824     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06686.x     Document Type: Article

References (23)

1. Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am. J. Gastroenterol. 2006; 101: 1900-20; quiz 43.
2. Gerson LB, Shetler K, Triadafilopoulos G. Prevalence of Barrett's esophagus in asymptomatic individuals. Gastroenterology 2002; 123: 461-7.
3. Ronkainen J, Aro P, Storskrubb T etal. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand. J. Gastroenterol. 2005; 40: 275-85.
4. Fujiwara Y, Arakawa T. Epidemiology and clinical characteristics of GERD in the Japanese population. J. Gastroenterol. 2009; 44: 518-34.
5. Fass R, Dickman R. Clinical consequences of silent gastroesophageal reflux disease. Curr. Gastroenterol. Rep. 2006; 8: 195-201.
6. Nozu T, Komiyama H. Clinical characteristics of asymptomatic esophagitis. J. Gastroenterol. 2008; 43: 27-31.
7. Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N. Engl. J. Med. 1999; 340: 825-31.
8. Hill LD, Kozarek RA, Kraemer SJ etal. The gastroesophageal flap valve: in vitro and in vivo observations. Gastrointest. Endosc. 1996; 44: 541-7.
9. Zagari RM, Fuccio L, Wallander MA etal. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study. Gut 2008; 57: 1354-9.
10. Armstrong D, Bennett JR, Blum AL etal. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111: 85-92.
11. Fauci AS, Braunwald E, Kasper DL etal. Harrison's Principles of Internal Medicine, 17 edn. New York: McGraw-Hill, 2008.
12. Peng S, Cui Y, Xiao YL etal. Prevalence of erosive esophagitis and Barrett's esophagus in the adult Chinese population. Endoscopy 2009; 41: 1011-7.
13. Wang FW, Tu MS, Chuang HY, Yu HC, Cheng LC, Hsu PI. Erosive esophagitis in asymptomatic subjects: risk factors. Dig. Dis. Sci. 2010; 55: 1320-4.
14. Arendt-Nielsen L, Bajaj P, Drewes AM. Visceral pain: gender differences in response to experimental and clinical pain. Eur. J. Pain 2004; 8: 465-72.
15. Nguyen P, Lee SD, Castell DO. Evidence of gender differences in esophageal pain threshold. Am. J. Gastroenterol. 1995; 90: 901-5.
16. Lasch H, Castell DO, Castell JA. Evidence for diminished visceral pain with aging: studies using graded intraesophageal balloon distension. Am. J. Physiol. 1997; 272: G1-3.
17. Shi Y, Weingarten TN, Mantilla CB, Hooten WM, Warner DO. Smoking and pain: pathophysiology and clinical implications. Anesthesiology 2010; 113: 977-92.
18. Jamner LD, Girdler SS, Shapiro D, Jarvik ME. Pain inhibition, nicotine, and gender. Exp. Clin. Psychopharmacol. 1998; 6: 96-106.
19. Nam SY, Choi IJ, Ryu KH, Kim BC, Kim CG, Nam BH. Effect of Helicobacter pylori infection and its eradication on reflux esophagitis and reflux symptoms. Am. J. Gastroenterol. 2010; 105: 2153-62.
20. Hughes J, Lockhart J, Joyce A. Do calcium antagonists contribute to gastro-oesophageal reflux disease and concomitant noncardiac chest pain? Br. J. Clin. Pharmacol. 2007; 64: 83-9.
21. Ghoshal UC, Chourasia D. Gastroesophageal reflux disease and helicobacter pylori: what may be the relationship? J. Neurogastroenterol. Motil. 2010; 16: 243-50.
22. Son JI, Kim JJ, Park MK etal. The natural history of asymptomatic reflux esophagitis: a retrospective study from periodic health check-up program. Korean J. Neurogastroenterol. Motil. 2004; 10: 100-4.
23. Manabe N, Yoshihara M, Sasaki A, Tanaka S, Haruma K, Chayama K. Clinical characteristics and natural history of patients with low-grade reflux esophagitis. J. Gastroenterol. Hepatol. 2002; 17: 949-54.